Organon & Co | Kontanter Og Tilsvarende



Cash And Equivalent Endring Dato
Adcock Ingram Holdings ZAR 89.42M 17.72M 2024-06
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Celltrion KRW 972.66B 68.24B 2024-09
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Ecofibre AUD 6.74M 4.89M 2024-06
Gilead Sciences USD 9.99B 4.95B 2024-12
Glaxosmithkline GBP 3.87B 678M 2024-12
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 35.7M 6.4M 2024-06
Medical Developments International AUD 9.74M 5.96M 2024-06
Merck USD 13.24B 1.35B 2024-12
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Novartis USD 11.46B 2.15B 2024-12
Organon & Co USD 675M 88M 2024-12
Pharma Mar EUR 63.24M 28.44M 2024-12
Qiagen NV USD 663.56M 309.42M 2024-12
Sartorius EUR 579.2M 12M 2024-09
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Tilray USD 189.7M 15.49M 2024-11



Organon & Co Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.